FDA Approved: KISQALI FEMARA CO-PACK — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved the Kisqali Femara co-pack, combining ribociclib with letrozole for the treatment of hormone receptor-positive, HER2-negative breast cancer in post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• KISQALI (ribociclib)

Snippet

ORIG AP for KISQALI FEMARA CO-PACK (LETROZOLE AND RIBOCICLIB)